Food And Drug Administration Approves Brand Brand New Libido-Boosting Drug for Premenopausal Females The usa Food and Drug Administration (Food And Drug Administration) today authorized bremelanotide (Vyleesi, AMAG Pharmaceuticals), a melanocortin that is first-in-class receptor agonist for hypoactive sexual interest disorder (HSDD) in premenopausal women. It joins flibanserin (Addyi, Sprout Pharmaceuticals), the only real other...Read More